ArticleTransboundary and emerging diseases2026
A Natural Recombinant NADC30-Like PRRSV Strain in China: Intersection of CH-1a, QYYZ, and JXA1 Lineages.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pathogenicity and virulence of PRRSV: From regulated cell death reprogramming landscape and immune subversion to precision vaccinology.Virulence · 2026Review
- Repeated Cross-Sectional Surveillance and ORF5-Based Molecular Epidemiology of Porcine Reproductive and Respiratory Syndrome Virus in Anhui Province, China, 2019-2024.Animals : an open access journal from MDPI · 2026Article
- A Natural Recombinant NADC30-Like PRRSV Strain in China: Intersection of CH-1a, QYYZ, and JXA1 Lineages.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) remains a major threat to global swine production. In this study, a novel strain (PRRSV-AH1) was isolated during a respiratory disease outbreak at a commercial swine operation in Anhui Province, China. Viral replication in MARC-145 cells was confirmed by observing cytopathic effects (CPEs) and conducting immunofluorescence assays (IFAs). Whole-genome sequencing revealed a 15,020 bp genome exhibiting 90.0% identity with the NADC30 reference strain, including lineage 1-characteristic nonstructural polyprotein (Nsp)2 deletions. A distinctive L10S substitution in GP2 aligned with conserved residues of PRRSV-1. Recombination analysis identified PRRSV-AH1 as a novel chimera with a NADC30-like backbone incorporating CH-1a-like (lineage 8), JXA1-like (lineage 8), and QYYZ-like (lineage 3) sequences-representing the first reported instance of this specific recombination pattern. Experimental infection of piglets induced characteristic PRRSV pathology, including sustained pyrexia, reduced weight gain, prolonged viremia, and neutralizing antibody seroconversion. Comparative pathogenicity analysis revealed that the PRRSV-AH1 strain elicited febrile responses and peak body temperatures intermediate between classic NADC30-like strains and JXA1 strains. Notably, PRRSV-AH1 demonstrated a PRRSV-N-specific IgG induction capacity comparable to that of highly pathogenic variants. These findings establish PRRSV-AH1 as a multilineage recombinant (NADC30-like, CH-1a, QYYZ, and JXA1 Lineages) resulting from multiple genetic exchanges, underscoring the increasing complexity of PRRSV diversity in China. Accelerated mutation and recombination across lineages complicate disease control efforts, emphasizing the need for enhanced surveillance, mechanistic recombination studies, and the development of novel vaccines to mitigate future outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.